INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 46h ago
House PTR6h ago
SEC 13F6h ago
Robinhood Chain6h ago

Most active filers · 30d

  1. 01Kurtz George0B / 217S · 10 late217 trades$54.77M
  2. 02SPSaba Capital Management, L.P.55B / 19S · 3 late74 trades$23.87M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04CFCheng Chi Fung0B / 42S42 trades$15.33M
  5. 05RARothblatt Martine A0B / 33S33 trades$5.50M
  6. 06RJRubinstein Julie0B / 32S32 trades$5.55M
  7. 07LBLeach Bryan0B / 30S30 trades$7.97M
  8. 08AOAtay Oguzhan0B / 30S30 trades$7.55M
  9. 09JDJenkins William D Jr0B / 30S30 trades$13.38M
  10. 10BSBiswas Sanjit0B / 28S28 trades$22.33M

Form 4 transactions

66,143 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
14
CE
Cooper Jeffrey ElliottChief Financial Officer
GWREGuidewire Software, Inc.
Open-market sale · 10b5-1 plan
SELL$144K
994 sh
Sep 18, 2026
Page 287 of 1654
← PrevNext →
Sep 21, 2026
traded Sep 18, 2026
+3d
SEC Form 4

Evidence

14
KV
Kuzoyan VaheDirector, President
TTANServiceTitan, Inc.
Derivative conversion
C—
3,148 sh
Sep 17, 2026Sep 21, 2026
traded Sep 17, 2026
+4dSEC Form 4

Evidence

14
CE
Cooper Jeffrey ElliottChief Financial Officer
GWREGuidewire Software, Inc.
Open-market sale · 10b5-1 plan
SELL$120K
854 sh
Sep 18, 2026Sep 21, 2026
traded Sep 18, 2026
+3dSEC Form 4

Evidence

13
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$19K
80 sh
Sep 17, 2026Sep 21, 2026
traded Sep 17, 2026
+4dSEC Form 4

Evidence

13
HB
Hohl BenjaminCHIEF FINANCIAL OFFICER
ELVNEnliven Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$177K
3,535 sh
Sep 17, 2026Sep 21, 2026
traded Sep 17, 2026
+4dSEC Form 4

Evidence

13
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$28K
120 sh
Sep 17, 2026Sep 21, 2026
traded Sep 17, 2026
+4dSEC Form 4

Evidence

13
BM
Bowen Julie MarieDirector
BUKSBUTLER NATIONAL CORP
Grant or award
A$13K
3,197 sh
Sep 21, 2026Sep 21, 2026
traded Sep 21, 2026
+0dSEC Form 4

Evidence

13
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$29K
120 sh
Sep 18, 2026Sep 21, 2026
traded Sep 18, 2026
+3dSEC Form 4

Evidence

13
RP
Raman PrakashDirector
BDTXBlack Diamond Therapeutics, Inc.
Grant or award
A$13K
6,801 sh
Sep 18, 2026Sep 21, 2026
traded Sep 18, 2026
+3dSEC Form 4

Evidence

13
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$32K
131 sh
Sep 18, 2026Sep 21, 2026
traded Sep 18, 2026
+3dSEC Form 4

Evidence

13
SD
Siegel Andrew DavidDirector
DAKTDAKTRONICS INC /SD/
Grant or award
A—
6,594 sh
Sep 17, 2026Sep 21, 2026
traded Sep 17, 2026
+4dSEC Form 4

Evidence

13
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$30K
120 sh
Sep 17, 2026Sep 21, 2026
traded Sep 17, 2026
+4dSEC Form 4

Evidence

13
BJ
Baker Christopher J.Director, See Remarks
KLXEKLX Energy Services Holdings, Inc.
Option exercise
M—
38.9K sh
Sep 21, 2026Sep 21, 2026
traded Sep 21, 2026
+0dSEC Form 4

Evidence

13
CL
Collins Helen LouiseCHIEF MEDICAL OFFICER
ELVNEnliven Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$94K
1,844 sh
Sep 17, 2026Sep 21, 2026
traded Sep 17, 2026
+4dSEC Form 4

Evidence

13
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$19K
80 sh
Sep 17, 2026Sep 21, 2026
traded Sep 17, 2026
+4dSEC Form 4

Evidence

13
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$28K
120 sh
Sep 17, 2026Sep 21, 2026
traded Sep 17, 2026
+4dSEC Form 4

Evidence

13
HB
Hohl BenjaminCHIEF FINANCIAL OFFICER
ELVNEnliven Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$111K
2,194 sh
Sep 17, 2026Sep 21, 2026
traded Sep 17, 2026
+4dSEC Form 4

Evidence

13
CL
Collins Helen LouiseCHIEF MEDICAL OFFICER
ELVNEnliven Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$146K
2,916 sh
Sep 17, 2026Sep 21, 2026
traded Sep 17, 2026
+4dSEC Form 4

Evidence

13
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$19K
80 sh
Sep 17, 2026Sep 21, 2026
traded Sep 17, 2026
+4dSEC Form 4

Evidence

13
KL
Kirchhoff Benjamin LouisCHIEF ACCOUNTING OFFICER
IOTSamsara Inc.
Open-market sale · 10b5-1 plan
SELL$31K
770 sh
Sep 18, 2026Sep 21, 2026
traded Sep 18, 2026
+3dSEC Form 4

Evidence

12
MR
Malpani RaghavendraCPO & CTO
PATHUiPath, Inc.
Open-market sale · 10b5-1 plan
SELL$567K
40.5K sh
Sep 17, 2026Sep 21, 2026
traded Sep 17, 2026
+4dSEC Form 4

Evidence

12
FA
Fichera AlfredDirector
HTGCHercules Capital, Inc.
Grant or award
A$62K
3,483 sh
Sep 17, 2026Sep 21, 2026
traded Sep 17, 2026
+4dSEC Form 4

Evidence

11
SB
Sousa Mauad BrunoDirector
AUGOAura Minerals Inc.
Derivative conversion
C$6.05M
208.4K sh
Sep 18, 2026Sep 21, 2026
traded Sep 18, 2026
+3dSEC Form 4

Evidence

11
RG
Rosenbaum Michael GeorgeDirector, Chief Executive Officer
GWREGuidewire Software, Inc.
Open-market sale · 10b5-1 plan
SELL$175K
1,200 sh
Sep 21, 2026Sep 21, 2026
traded Sep 21, 2026
+0dSEC Form 4

Evidence

10
AK
Akinsanya KarenSee Remarks
SDGRSchrodinger, Inc.
Option exercise · 10b5-1 plan
M$137K
31.6K sh
Sep 17, 2026Sep 21, 2026
traded Sep 17, 2026
+4dSEC Form 4

Evidence

9
PG
Parry GrahamChief Scientific Officer
ETRAElectra Therapeutics, Inc.
Derivative conversion
C—
85.5K sh
Sep 21, 2026Sep 21, 2026
traded Sep 21, 2026
+0dSEC Form 4

Evidence

9
DA
Di Beasi AlisaSVP and CHRO
PHINPHINIA INC.
Grant or award
A—
32 sh
Sep 18, 2026Sep 21, 2026
traded Sep 18, 2026
+3dSEC Form 4

Evidence

9
MJ
McMullen JamesController
ACTEnact Holdings, Inc.
Grant or award
A—
3 sh
Sep 17, 2026Sep 21, 2026
traded Sep 17, 2026
+4dSEC Form 4

Evidence

9
BM
Bunch John MarkCOO
EPMEVOLUTION PETROLEUM CORP
Grant or award
A—
45.6K sh
Sep 17, 2026Sep 21, 2026
traded Sep 17, 2026
+4dSEC Form 4

Evidence

9
DA
Ding AdrianChief Financial Officer
YUMCYum China Holdings, Inc.
Grant or award
A—
134 sh
Sep 17, 2026Sep 21, 2026
traded Sep 17, 2026
+4dSEC Form 4

Evidence

9
DJ
DING JerryChief People Officer
YUMCYum China Holdings, Inc.
Grant or award
A—
25 sh
Sep 17, 2026Sep 21, 2026
traded Sep 17, 2026
+4dSEC Form 4

Evidence

9
ZL
Zhang LeilaChief Technology Officer
YUMCYum China Holdings, Inc.
Grant or award
A—
22 sh
Sep 17, 2026Sep 21, 2026
traded Sep 17, 2026
+4dSEC Form 4

Evidence

9
LP
LIU PingpingChief Legal Officer
YUMCYum China Holdings, Inc.
Grant or award
A—
9 sh
Sep 17, 2026Sep 21, 2026
traded Sep 17, 2026
+4dSEC Form 4

Evidence

9
SN
Stagliano NancyDirector
ETRAElectra Therapeutics, Inc.
Derivative conversion
C—
255.6K sh
Sep 21, 2026Sep 21, 2026
traded Sep 21, 2026
+0dSEC Form 4

Evidence

9
DJ
DING JerryChief People Officer
YUMCYum China Holdings, Inc.
Option exercise
M—
9 sh
Sep 17, 2026Sep 21, 2026
traded Sep 17, 2026
+4dSEC Form 4

Evidence

9
LX
Lu XuelingController and PAO
YUMCYum China Holdings, Inc.
Grant or award
A—
27 sh
Sep 17, 2026Sep 21, 2026
traded Sep 17, 2026
+4dSEC Form 4

Evidence

9
FJ
Fischer JamieChief Operating Officer
CRMTAMERICAS CARMART INC
Tax withholding
F$676
380 sh
Sep 17, 2026Sep 21, 2026
traded Sep 17, 2026
+4dSEC Form 4

Evidence

9
DJ
DING JerryChief People Officer
YUMCYum China Holdings, Inc.
Tax withholding
F$207
5 sh
Sep 17, 2026Sep 21, 2026
traded Sep 17, 2026
+4dSEC Form 4

Evidence

9
DJ
DING JerryChief People Officer
YUMCYum China Holdings, Inc.
Grant or award
A—
2 sh
Sep 17, 2026Sep 21, 2026
traded Sep 17, 2026
+4dSEC Form 4

Evidence

9
WJ
Wat JoeyDirector, Chief Executive Officer
YUMCYum China Holdings, Inc.
Grant or award
A—
612 sh
Sep 17, 2026Sep 21, 2026
traded Sep 17, 2026
+4dSEC Form 4

Evidence

Cluster activity · 60d

  1. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  2. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  3. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  4. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  5. SELLIBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
  6. BUYMTDRMatador Resources CoNov 5 – Nov 56 insiders$507K
  7. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
  8. BUYBBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K